Literature DB >> 14666412

Homocysteinemia in psychiatric disorders: association with dementia and depression, but not schizophrenia in female patients.

A Reif1, M F Schneider, S Kamolz, B Pfuhlmann.   

Abstract

Homocysteinemia has been reported to be a risk factor for dementia, depression and also schizophrenia, the latter in a gender-specific manner. We have determined homocysteine in female inpatients suffering from various psychiatric diseases to further investigate a possible association between homocysteinemia and psychiatric disorders. Homocysteine was not elevated in schizophrenic females (mean, 11.6+/-5.8 micromol/l); in accordance with previous studies, homocysteinemia could be found frequently in dementia of different aetiology (mean, 17.2+/-6.7 micromol/l), but also to a slighter extent in depressive disorders (mean, 12.9+/-3.8 micromol/l), especially in elderly subjects. We thus suggest that homocysteinemia, at least in females, is an unspecific risk factor for organic brain disorders, but not endogenous psychoses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666412     DOI: 10.1007/s00702-003-0061-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  7 in total

1.  Molecular basis of reduced pyridoxine 5'-phosphate oxidase catalytic activity in neonatal epileptic encephalopathy disorder.

Authors:  Faik N Musayev; Martino L Di Salvo; Mario A Saavedra; Roberto Contestabile; Mohini S Ghatge; Alexina Haynes; Verne Schirch; Martin K Safo
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

2.  Homocysteine and cognition in first-episode psychosis patients.

Authors:  Rosa Ayesa-Arriola; Rocío Pérez-Iglesias; José Manuel Rodríguez-Sánchez; Ignacio Mata; Elsa Gómez-Ruiz; Maite García-Unzueta; Obdulia Martínez-García; Rafael Tabares-Seisdedos; Jose L Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-02       Impact factor: 5.270

Review 3.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

4.  Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats.

Authors:  Bárbara Tagliari; Tiago M dos Santos; Aline A Cunha; Daniela D Lima; Débora Delwing; Angela Sitta; Carmem R Vargas; Carla Dalmaz; Angela T S Wyse
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

Review 5.  Psychiatric signs and symptoms in treatable inborn errors of metabolism.

Authors:  S Nia
Journal:  J Neurol       Date:  2014-09       Impact factor: 4.849

Review 6.  Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.

Authors:  Anna K Jönsson; Johan Schill; Hans Olsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

7.  Elevated homocysteine, as a biomarker of cardiac injury, in panic disorder patients due to oxidative stress.

Authors:  Seyed Shahrokh Aghayan; Asghar Farajzadeh; Zahra Bagheri-Hosseinabadi; Homeyra Fadaei; Maryam Yarmohammadi; Moslem Jafarisani
Journal:  Brain Behav       Date:  2020-09-23       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.